Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
4
Neutral
6
Bullish
4
Bearish
33
Neutral
6
Bullish
7
Bearish
29
Neutral
0
Bullish
3
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
153.70 | 1,774 Cr | 14.80 | 1.76 | 0.49 | 11.86 | 15.46 | 8.96 | ||
770.50 | 1,718 Cr | -21.23 | 4.40 | 0.00 | -20.72 | -5.54 | -8.59 | ||
47.29 | 1,203 Cr | 41.86 | 0.78 | 0.00 | 1.86 | 6.75 | 0.95 | ||
920.00 | 1,135 Cr | 17.75 | 2.68 | 0.32 | 15.10 | 17.43 | 7.77 | ||
273.60 | 925 Cr | 16.92 | 2.06 | 0.00 | 12.17 | 15.44 | 6.50 | ||
172.60 | 691 Cr | -9.04 | 0.91 | 0.00 | -10.03 | -1.57 | -3.94 | ||
99.10 | 637 Cr | 18.05 | 2.17 | 0.00 | — | — | 0.00 | ||
| Median: 7 Co. | — | 172.60 | 1,135 Cr | 16.92 | 2.06 | 0.00 | 6.86 | 11.09 | 0.95 |
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Meghmani Organics Limited is primarily engaged in the production and sale of pigments, agrochemicals, and specialized chemical products with a global footprint in over 75 countries.
The company faced a decline in Q3 FY26 revenue by 13% YoY, mainly due to uncertain US trade policies impacting demand, yet it saw notable growth in its Nano Urea product lineup.
Despite challenges in the export markets, Meghmani has a strong focus on sustainable agriculture, with significant investments in Nano Urea production to boost crop yield and environmental health.
Meghmani's strategic expansion through the commissioning of production plants for new products like Nano Urea and titanium dioxide positions it as a forward-thinking player looking to capture new market opportunities.
The organization's leadership, under the guidance of Mr. Ankit Patel, reflects a robust approach towards navigating economic uncertainties with a focus on strategic diversification and market resilience.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
1,203 Cr
High Risk
41.9
20.9
0.5
0.8
106.03
36.41
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Meghmani Organics Ltd (MOL) is currently trading at 48.01 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Meghmani Organics Limited is primarily engaged in the production and sale of pigments, agrochemicals, and specialized chemical products with a global footprint in over 75 countries. The company faced a decline in Q3 FY26 revenue by 13% YoY, mainly due to uncertain US trade policies impacting demand, yet it saw notable growth in its Nano Urea product lineup. Despite challenges in the export markets, Meghmani has a strong focus on sustainable agriculture, with significant investments in Nano Urea production to boost crop yield and environmental health. Meghmani's strategic expansion through the commissioning of production plants for new products like Nano Urea and titanium dioxide positions it as a forward-thinking player looking to capture new market opportunities. The organization's leadership, under the guidance of Mr. Ankit Patel, reflects a robust approach towards navigating economic uncertainties with a focus on strategic diversification and market resilience.
Over the past 52 weeks, Meghmani Organics Ltd has traded between a low of ₹36.41 and a high of ₹106.03. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Meghmani Organics Ltd has a market capitalization of approximately 1,202.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Meghmani Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,202.65 Cr, Meghmani Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Meghmani Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Meghmani Organics Ltd is 41.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Meghmani Organics is proposing to amalgamate Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited with Meghmani Organics Limited as the transferee company.
It is a plan to merge its wholly-owned subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics Limited, with an appointed date of January 1, 2026.
The stock saw sustained selling pressure through the week ending 6 March 2026, alongside concerns highlighted in the note around losses, falling sales and rising interest costs.
Amalgamation Approval
Meghmani Organics' NCLT‑convened shareholders meeting (held June 6, 2026; remote e‑voting June 3–5) approved by special resolution the scheme to amalgamate Kilburn Chemicals Ltd and Meghmani Crop Nutrition Ltd into Meghmani Organics; passed with 99.99% votes in favour per scrutinizer's report.
Creditor Meeting Summary
Summary of proceedings of the NCLT‑convened meeting of Meghmani Organics' unsecured creditors held on 6 June 2026 via VC to consider the Scheme of Amalgamation; remote e‑voting conducted and results to be disseminated.
NCLT Meeting Summary
Summary of proceedings of the NCLT‑convened meeting of Meghmani Organics' unsecured creditors held on 06‑Jun‑2026 to consider the scheme of amalgamation with Kilburn Chemicals and Meghmani Crop Nutrition; remote e‑voting (03–05 Jun) was provided and Ms. Pavni Lakhanpal acted as scrutinizer.
NCLT Meeting Outcome
Summary of secured creditors' NCLT‑convened meeting held on 6 June 2026 via VC to consider the Scheme of Amalgamation between Kilburn Chemicals Ltd, Meghmani Crop Nutrition Ltd and Meghmani Organics Ltd; e‑voting held June 3–5; scrutinizer appointed.
Scheme of Amalgamation
Meghmani Organics held an NCLT‑convened shareholders meeting on 6 June 2026 (VC) to consider a special resolution to amalgamate Kilburn Chemicals Ltd and Meghmani Crop Nutrition Ltd into Meghmani Organics; e‑voting results due by 9 June 2026.
Scheme of Amalgamation
Meghmani Organics held an NCLT‑convened shareholders meeting on 06 Jun 2026 to consider a scheme to amalgamate Kilburn Chemicals and Meghmani Crop Nutrition into Meghmani Organics; e‑voting was enabled and results to be announced by 09 Jun 2026.
